Health technology assessment on the use of magnetic resonance imaging (MRI) and computed tomography (CT) in the diagnosis of multiple sclerosis (MS) and clinically isolated syndromes (CIS)

European Journal of Radiology

Volumn 65, Issue 2, 2008, Pages 211-213

  Achten, Eric ^a   Deblaere, Karel ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Computer tomography (CT); Health technology assessment (HTA); Magnetic resonance imaging (MRI); Multiple sclerosis

Indexed keywords

BRAIN; COMPUTERIZED TOMOGRAPHY; DATABASE SYSTEMS; MAGNETIC RESONANCE IMAGING; RADIOLOGY;

CLINICALLY ISOLATED SYNDROMES (CIS); HEALTH TECHNOLOGY ASSESSMENT (HTA); MULTIPLE SCLEROSIS;

PATIENT TREATMENT;

GADOLINIUM CHELATE;

ARTICLE; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MEDICAL EXAMINATION; MULTIPLE SCLEROSIS; NASOPHARYNX TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SENSITIVITY AND SPECIFICITY; SYNDROME; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 38749092203     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.11.014     Document Type: Article

References (21)

1. Young I.R., Hall A.S., Pallis C.A., et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 2 (1981) 1063-1066
2. Mastaglia F.L., and Cala L.A. Nuclear magnetic resonance imaging (NMR) and computerised tomography (CT) in multiple sclerosis. Lancet 1 (1982) 850
3. Moseley I. Computed tomography and nuclear magnetic resonance imaging of the brain in multiple sclerosis: a review. Bull Soc Belge Ophtalmol 208 (1983) 63-76
4. Crooks L.E., Mills C.M., Davis P.L., et al. Visualization of cerebral and vascular abnormalities by NMR imaging. The effects of imaging parameters on contrast nuclear magnetic resonance whole-body imager operating at 3.5 kgauss. Radiology 144 (1982) 843-852
5. Brant-Zawadzki M., Davis P.L., Crooks L.E., et al. NMR demonstration of cerebral abnormalities: comparison with CT. AJR Am J Roentgenol 140 (1983) 847-854
6. Lukes S.A., Crooks L.E., Aminoff M.J., et al. Nuclear magnetic resonance imaging in multiple sclerosis. Ann Neurol 13 (1983) 592-601
7. Sears E.S. Nuclear magnetic resonance versus computerized tomographic enhancement imaging in multiple sclerosis: an apples and oranges comparison?. Ann Neurol 15 (1984) 309-310
8. Sheldon J.J., Siddharthan R., Tobias J., et al. MR imaging of multiple sclerosis: comparison with clinical and ct examinations in 74 patients. AJR Am J Roentgenol 145 (1985) 957-964
9. Jacobs L., Kinkel W.R., Polachini I., and Kinkel R.P. Correlations of nuclear magnetic resonance imaging, computerized tomography, and clinical profiles in multiple sclerosis. Neurology 36 (1986) 27-34
10. Osborn A.G., Harnsberger H.R., Smoker W.R., and Boyer R.S. Multiple sclerosis in adolescents: CT and MR findings. AJR Am J Roentgenol 155 (1990) 385-390
11. Nesbit G.M., Forbes G.S., Scheithauer B.W., et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180 (1991) 467-474
12. Paty D.W., Oger J.J., Kastrukoff L.F., et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 38 (1988) 180-185
13. Lee K.H., Hashimoto S.A., Hooge J.P., et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 41 (1991) 657-660
14. Carr D.H. The use of iron and gadolinium chelates as NMR contrast agents: animal and human studies. Physiol Chem Phys Med NMR 16 (1984) 137-144
15. Goldstein E.J., Burnett K.R., Hansell J.R., et al. Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics. Physiol Chem Phys Med NMR 16 (1984) 97-104
16. Laniado M., Weinmann H.J., Schorner W., et al. First use of gddtpa/dimeglumine in man. Physiol Chem Phys Med NMR 16 (1984) 157-165
17. Poser C.M. MRI and CT scan in multiple sclerosis. JAMA 253 (1985) 3250
18. Brant-Zawadzki M., Berry I., Osaki L., et al. Gd-dtpa in clinical MR of the brain: 1. Intraaxial lesions. AJR Am J Roentgenol 147 (1986) 1223-1230
19. Grossman R.I., Gonzalez-Scarano F., Atlas S.W., et al. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 161 (1986) 721-725
20. Valk J., de Slegte R.G., Crezee F.C., et al. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-dtpa. Acta Radiol 28 (1987) 659-665
21. Ziporyn T. Magnetic resonance 'sees' lesions of multiple sclerosis. JAMA 253 (1985) 949-951